특허실적

Use of purine ribonucleoside and its derivative as beta-lactamase inhibitor

https://doi.org/10.8080/1020160090725

Use of β-nicotinamide adenine dinucleotide 2’-phosphate reduced (NADPH) and its derivatives as beta-lactamase inhibitors

https://doi.org/10.8080/1020170093364

Licensing-out ₩ 500,000,000 (up-front payment + milestone payment)

Antibodies regulating functions of an endothelin receptor type A

https://doi.org/10.8080/1020190159941

Licensing-out ₩ 900,000,000 (up-front payment + milestone payment)

Antibody with enhanced binding to endothelin receptor type A

https://doi.org/10.8080/1020200060976

Licensing-out ₩ 2,000,000,000 (up-front payment + milestone payment)

Flavin mononucleotide binding protein variants derived from Arabidopsis thaliana with enhanced fluorescence intensity

https://doi.org/10.8080/1020190120443

Flavin mononucleotide binding protein variants derived from Pseudomonas putida with enhanced fluorescence intensity

https://doi.org/10.8080/1020200108735

@Copyright 2020. Jung-Hyun Na all rights reserved.